Last reviewed · How we verify
A Phase 1, Open-Label, 2-Period, Sequential, Drug-Drug Interaction Study To Determine The Effect Of Lithium 600 Mg BID On The Safety And Pharmacokinetics Of Lurasidone 120 Mg QD In Patients With Schizophrenia Or Schizoaffective Disorder
The purpose of this study is to evaluate the drug-drug interaction effect between Lithium and Lurasidone HCl.
Details
| Lead sponsor | Sumitomo Pharma America, Inc. |
|---|---|
| Phase | Phase 1 |
| Status | COMPLETED |
| Enrolment | 24 |
| Start date | 2008-08 |
| Completion | 2008-10 |
Conditions
- Schizophrenia
Interventions
- Lurasidone HCl
Countries
United States